StockWatch
·
Pharmaceuticals
Clarification14 Aug 2026, 07:40 pm

Rekvina Laboratories Denies Knowledge of Price Movement Factors

AI Summary

Rekvina Laboratories Limited has responded to stock exchange queries regarding significant price movements in its securities. The company stated it is unaware of any specific information, event, or impending announcement that could be influencing the price, beyond what has already been disclosed. Rekvina confirmed its compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and asserted that no undisclosed price-sensitive information or material events are being withheld. The company attributes the price and volume fluctuations to market-driven factors.

Key Highlights

  • Company unaware of specific reasons for price movement.
  • No undisclosed price-sensitive information exists.
  • Regular compliance with SEBI LODR regulations confirmed.
  • Price movement attributed to market-driven factors.